MS-HRM results showed that the methylation states of the GFRA1 and GSTM2 promoters were not associated with rectal cancer stage (data not shown), but that aberrant methylation of these two genes may play roles in the pathogenesis of rectal cancer. The gene discussed is GFRA1; the disease is rectal cancer.